Outsourced Pharma White Papers
-
Leveraging Efficiency From CLD To Clinical Manufacturing Of mAbs
4/23/2025
Discover how our efficient strategies can propel your mAb from discovery to clinical manufacturing in as little as 18 months.
-
The Relevance Of Polymorph Screening In The Pharmaceutical Industry
3/31/2025
Polymorph screening identifies different solid forms of active pharmaceutical ingredients, optimizing drug stability, solubility, and manufacturability. This process ensures quality, regulatory compliance, and intellectual property protection in pharmaceutical development.
-
Viral Disinfectant Efficacy Studies: Key Guiding Factors And Design Elements
4/8/2025
Viral Disinfectant Efficacy Studies validate cleaning protocols in pharma facilities, ensuring regulatory compliance, reducing contamination risk, and supporting safe, effective disinfection with expert CRO guidance.
-
Pioneering Plasmid-IQ Design
5/13/2025
Gain insights into the significance of plasmid design in viral vector production and the use of analytical assays and Next-Generation Sequencing for plasmid verification.
-
White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges
10/16/2024
Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.
-
Optimizing DSP Development: Faster Timelines, Lower Costs, And High-Quality Processes
4/8/2025
The biopharmaceutical industry faces growing downstream processing challenges in purifying complex biologics efficiently and at scale.
-
Predictive Modeling Of Viscosity Behavior Using Artificial Neural Networks
9/11/2023
Discover a modeling approach employing artificial neural networks using experimental factors combined with simulation-derived parameters plus viscosity data from 27 highly concentrated mAbs.
-
Analytical Techniques For Characterization, Release, And Stability Testing
4/28/2025
Review the analytical considerations for subunit vaccines, vaccines that contain only the antigenic component(s) of a pathogen, and more specifically the assays needed.
-
Microbial Challenge In-Use Studies
6/13/2024
Learn more about how a partner with expertise can help you navigate the complex landscape of microbial challenge in-use studies and ensure the highest standards of patient care.
-
Performance Characteristics Of The MobiusĀ® ADC Reactor For Conjugation
10/22/2024
Explore results from a series of studies evaluating the mixing performance of an innovative ADC reactor during the conjugation step utilizing a model fluid.